Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow

被引:111
作者
Sanz, C. [1 ,2 ]
Vazquez, P. [1 ,2 ,3 ]
Blazquez, C. [4 ,5 ]
Barrio, P. A. [1 ,2 ]
Alvarez, M. Del M. [1 ]
Blazquez, E. [1 ,2 ]
机构
[1] Univ Complutense, Dept Bioquim & Biol Mol, Fac Med, E-28040 Madrid, Spain
[2] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain
[3] CSIC, Ctr Invest Biol, Madrid, Spain
[4] Hosp La Princesa, Serv Hematol, Madrid, Spain
[5] Hosp Jerez, Serv Hematol, Jerez de la Frontera, Spain
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2010年 / 298卷 / 03期
关键词
human mesenchymal stem cell; proliferation; adipogenesis; cytoprotection; FIBROBLAST-GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; ADIPOCYTE DIFFERENTIATION; IN-VIVO; DIABETES-MELLITUS; RAT-BRAIN; INNER-EAR; RECEPTOR; GLUCOSE; EXPRESSION;
D O I
10.1152/ajpendo.00460.2009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sanz C, Vazquez P, Blazquez C, Barrio PA, Alvarez MM, Blazquez E. Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow. Am J Physiol Endocrinol Metab 298: E634-E643, 2010. First published December 29, 2009; doi:10.1152/ajpendo.00460.2009.-Glucagon-like peptide 1 (GLP-1) functions as an incretin hormone with antidiabetogenic properties. However, the role of GLP-1 in human bone marrow-derived mesenchymal stem cells (hMSCs), if any, remains unknown. The effects of GLP-1 on hMSCs were tested with regard to cell proliferation, cytoprotection, and cell differentiation into adipocytes. The signaling pathways involved in these processes were also analyzed. Cells were characterized with biochemical and morphological approaches before and after being induced to differentiate into adipocytes. PCNA protein levels were used as a proliferation index, whereas cell apoptosis was studied by deprivation of fetal bovine serum. Isolated hMSCs expressed stem cell markers as well as mRNA and GLP-1 receptor protein. GLP-1 increased the proliferation of hMSCs, which decreased when they were induced to differentiate into adipocytes. This process produced biochemical and morphological changes in cells expressing PPAR gamma, C/EBP beta, AP2, and LPL in a time-dependent pattern. Notably, GLP-1 significantly reduced the expression of PPAR gamma, C/EBP beta, and LPL. These effects were exerted at least through the MEK and PKC signaling pathways. In addition, GLP-1 significantly reduced cell apoptosis. Our data indicate that, in hMSCs, GLP-1 promotes cellular proliferation and cytoprotection and prevents cell differentiation into adipocytes. These latter findings underscore the potential therapeutic role of GLP-1 in preventing the adipocyte hyperplasia associated with obesity and, additionally, could bolster the maintenance of hMSC stores by promoting the proliferation and cytoprotection of undifferentiated hMSC.
引用
收藏
页码:E634 / E643
页数:10
相关论文
共 43 条
  • [11] Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
    During, MJ
    Cao, L
    Zuzga, DS
    Francis, JS
    Fitzsimons, HL
    Jiao, XY
    Bland, RJ
    Klugmann, M
    Banks, WA
    Drucker, DJ
    Haile, CN
    [J]. NATURE MEDICINE, 2003, 9 (09) : 1173 - 1179
  • [12] Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets
    Farilla, L
    Bulotta, A
    Hirshberg, B
    Calzi, SL
    Khoury, N
    Noushmehr, H
    Bertolotto, C
    Di Mario, U
    Harlan, DM
    Perfetti, R
    [J]. ENDOCRINOLOGY, 2003, 144 (12) : 5149 - 5158
  • [13] Protein kinase C isoforms play differential roles in the regulation of adipocyte differentiation
    Fleming, I
    MacKenzie, SJ
    Vernon, RG
    Anderson, NG
    Houslay, MD
    Kilgour, E
    [J]. BIOCHEMICAL JOURNAL, 1998, 333 : 719 - 727
  • [14] Developmental origin of fat: Tracking obesity to its source
    Gesta, Stephane
    Tseng, Yu-Hua
    Kahn, C. Ronald
    [J]. CELL, 2007, 131 (02) : 242 - 256
  • [15] Efficacy and Safety of Incretin-Based Therapies in Patients with Type 2 Diabetes Mellitus
    Gilbert, Matthew P.
    Pratley, Richard E.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2009, 122 (06) : 11 - 24
  • [16] Understanding adipocyte differentiation
    Gregoire, FM
    Smas, CM
    Sul, HS
    [J]. PHYSIOLOGICAL REVIEWS, 1998, 78 (03) : 783 - 809
  • [17] Growth factor properties of VIP during early brain development -: Whole embryo culture and in vivo studies
    Gressens, P
    Paindaveine, B
    Hill, JM
    Brenneman, DE
    Evrard, P
    [J]. NEUROPEPTIDES IN DEVELOPMENT AND AGING, 1997, 814 : 152 - 160
  • [18] ANTIDIABETOGENIC EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDE IN NORMAL SUBJECTS AND PATIENTS WITH DIABETES-MELLITUS
    GUTNIAK, M
    ORSKOV, C
    HOLST, JJ
    AHREN, B
    EFENDIC, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (20) : 1316 - 1322
  • [19] EFFECTS OF EPIDERMAL GROWTH-FACTOR (EGF), PLATELET-DERIVED GROWTH-FACTOR (PDGF) AND FIBROBLAST GROWTH-FACTOR (FGF) ON HUMAN ADIPOCYTE DEVELOPMENT AND FUNCTION
    HAUNER, H
    ROHRIG, K
    PETRUSCHKE, T
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1995, 25 (02) : 90 - 96
  • [20] Obesity and diabetes - potential for intervention?
    Hauner, H
    [J]. JOURNAL OF ENDOCRINOLOGY, 1997, 155 (02) : 223 - 223